PROMUS Element™ Plus BTK
Everolimus-Eluting Platinum Chromium Stent System
The PROMUS Element Plus Stent System establishes a new standard of drug-eluting stent performance with the combination of its highly visible Platinum Chromium alloy and innovative stent design for a superior compression resistance together with the market-leading Everolimus drug.
Explore
Product Details
PROMUS Element™ Plus BTK Stent Delivery System
![Stent Delivery System](https://www.bostonscientific.com/en-EU/products/stents-vascular/promus-element-plus-stent-system/_jcr_content/maincontent-par/image_0.img.promus_monorail-version_trans_960x140_eu.png)
Meet all clinical needs
Focal Resistant Lesions
When blood flow is limited by a focal lesion and PTA is not sufficient to establish good patency due to calcium or vessel recoil
Restenotic Lesions
To treat flow-limiting restenosis consequent to PTA or BMS procedures
Short Dissections
When a dissection occurs immediately after PTA
Discover superior performance
Visibility
Platinum Chromium
- More than twice compression resistance of Cobalt Chromium stents
- 40% less recoil than Cobalt-Chromium
- Exceptional visibility and radiopacity
Efficacy
The Everolimus Drug & Fluorinated Copolymer
- Exceptional efficacy
- Long-term safety
- Proven performance in over 1800 patients in Coronary PROMUS Platinum clinical program